Infographic: How Immunotherapy Could Boost Stem-Like T Cells
Infographic: How Immunotherapy Could Boost Stem-Like T Cells
Cancer therapies could potentially be more effective if their development took into account the cells that give rise to tumor-fighting cells.
Infographic: How Immunotherapy Could Boost Stem-Like T Cells
Infographic: How Immunotherapy Could Boost Stem-Like T Cells

Cancer therapies could potentially be more effective if their development took into account the cells that give rise to tumor-fighting cells.

Cancer therapies could potentially be more effective if their development took into account the cells that give rise to tumor-fighting cells.

dendritic cells
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
The Scientist's LabTalk Podcast - Episode 1
The Scientist's LabTalk Podcast - Episode 1
The Scientist Creative Services Team | Sep 11, 2020
Myeloid Cells in Cancer and Science Advocacy: A Conversation with Dr. Miriam Merad
Harnessing Stem Cell–Like T Cells to Better Fight Cancer
Harnessing Stem Cell–Like T Cells to Better Fight Cancer
Daniel E. Speiser and Werner Held | Jul 13, 2020
Better understanding the CD8+ T cells already present in tumors could be key to making immunotherapies work for more patients.
In Situ Vaccination: A Cancer Treatment a Century in the Making
In Situ Vaccination: A Cancer Treatment a Century in the Making
Emma Yasinski | Jul 25, 2019
Injecting immunostimulants directly into the tumor is not a new strategy to stimulate the immune system, but the approach has seen a surge of interest in recent years.
Image of the Day: Training Day
Image of the Day: Training Day
Chia-Yi Hou | May 24, 2019
A video captures T cells learning to recognize cells from the body that shouldn’t be attacked.
Cancer Vaxxer: A Profile of Miriam Merad
Cancer Vaxxer: A Profile of Miriam Merad
Anna Azvolinsky | Apr 1, 2019
The Mount Sinai oncologist studies innate immune cells with the goal of designing novel immunotherapies, including cancer vaccines.
New Ovarian Cancer Vaccine Shows Promise
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
Researchers Uncover Previously Unknown Immune Cell Subtypes
Researchers Uncover Previously Unknown Immune Cell Subtypes
Aggie Mika | Jul 16, 2017
Using single-cell RNA sequencing, scientists characterize new populations of dendritic cells and monocytes.
Fetal Immune System Operational by Second Trimester
Fetal Immune System Operational by Second Trimester
Abby Olena | Jun 14, 2017
Research shows that human immunity develops much earlier than previously thought, but functions differently in adults.